Synovus Financial’s Blueprint Medicines BPMC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.18M | Buy |
32,572
+416
| +1% | +$53.3K | 0.05% | 220 |
|
2025
Q1 | $2.85M | Buy |
32,156
+7,628
| +31% | +$675K | 0.04% | 281 |
|
2024
Q4 | $2.14M | Buy |
24,528
+481
| +2% | +$42K | 0.03% | 341 |
|
2024
Q3 | $2.22M | Buy |
24,047
+922
| +4% | +$85.3K | 0.03% | 354 |
|
2024
Q2 | $2.49M | Sell |
23,125
-7,796
| -25% | -$840K | 0.03% | 306 |
|
2024
Q1 | $2.93M | Sell |
30,921
-306
| -1% | -$29K | 0.04% | 279 |
|
2023
Q4 | $2.88M | Sell |
31,227
-8,971
| -22% | -$827K | 0.04% | 269 |
|
2023
Q3 | $2.02M | Sell |
40,198
-283
| -0.7% | -$14.2K | 0.02% | 334 |
|
2023
Q2 | $2.56M | Sell |
40,481
-2,632
| -6% | -$166K | 0.03% | 307 |
|
2023
Q1 | $1.94M | Sell |
43,113
-4,710
| -10% | -$212K | 0.02% | 338 |
|
2022
Q4 | $2.1M | Buy |
47,823
+13,466
| +39% | +$590K | 0.02% | 331 |
|
2022
Q3 | $2.26M | Buy |
34,357
+4,808
| +16% | +$317K | 0.03% | 298 |
|
2022
Q2 | $1.49M | Buy |
29,549
+2,826
| +11% | +$143K | 0.02% | 373 |
|
2022
Q1 | $1.7M | Buy |
26,723
+5,318
| +25% | +$339K | 0.02% | 356 |
|
2021
Q4 | $2.29M | Buy |
21,405
+219
| +1% | +$23.5K | 0.02% | 310 |
|
2021
Q3 | $2.17M | Buy |
21,186
+6,074
| +40% | +$623K | 0.02% | 294 |
|
2021
Q2 | $1.33M | Buy |
15,112
+790
| +6% | +$69.4K | 0.01% | 366 |
|
2021
Q1 | $1.39M | Buy |
+14,322
| New | +$1.39M | 0.02% | 317 |
|
2020
Q3 | – | Sell |
-63
| Closed | -$5K | – | 790 |
|
2020
Q2 | $5K | Hold |
63
| – | – | ﹤0.01% | 1311 |
|
2020
Q1 | $4K | Hold |
63
| – | – | ﹤0.01% | 1803 |
|
2019
Q4 | $5K | Hold |
63
| – | – | ﹤0.01% | 1302 |
|
2019
Q3 | $5K | Hold |
63
| – | – | ﹤0.01% | 1282 |
|
2019
Q2 | $6K | Hold |
63
| – | – | ﹤0.01% | 1189 |
|
2019
Q1 | $5K | Hold |
63
| – | – | ﹤0.01% | 1212 |
|
2018
Q4 | $3K | Hold |
63
| – | – | ﹤0.01% | 1262 |
|
2018
Q3 | $5K | Buy |
+63
| New | +$5K | ﹤0.01% | 1225 |
|